New evidence questions benefits of turmeric for knee arthritis
Supplements

New evidence questions benefits of turmeric for knee arthritis

By Marcus Reid · · 3 min read

Complex condition, limited options

Osteoarthritis is a complex joint disorder and the most common form of arthritis. While exercise and medication can manage symptoms, no definitive cure exists. Turmeric, a common spice, contains curcuminoids like curcumin, known for anti-inflammatory properties. Because inflammation worsens arthritis symptoms, turmeric supplements have attracted interest as a potential therapy.

Study details and methodology

An international team analyzed nine studies involving 1,245 people with knee osteoarthritis. These trials compared turmeric supplements with placebo, non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and diclofenac, and acetaminophen. The studies examined various turmeric extracts and curcuminoid products. Products differed in composition, curcuminoid content, and dosage. Participants had a median age between 52 and 62 years, with about two-thirds being women. The trials were conducted in Australia, Belgium, India, and Thailand. The tests were relatively short, lasting between four weeks and three months.

Clinical implications and expert view

Overall, current evidence does not demonstrate a clear clinical benefit. Compared with placebo and anti-inflammatory medications, turmeric did not prove more effective. However, available evidence remains uncertain due to limitations in the underlying studies. Dr. Ivan Shirinsky, lead author and active rheumatologist, states: „As a clinician and researcher, I am not surprised by these results. Osteoarthritis is a complex and still incompletely understood disease. ”Although intensive research has been conducted, effective pharmacological treatment options remain limited, and many promising approaches have generated limited or inconclusive evidence regarding clinical benefit. A better understanding of the mechanisms underlying osteoarthritis could help us develop more effective future treatments.

Previous systematic reviews generally suggested that turmeric could improve pain and physical function in people with osteoarthritis. However, some of these conclusions may have been influenced by studies whose reliability had not been formally assessed. The new Cochrane report integrated formal trial credibility assessments, providing additional protection when evaluating available evidence. Notably, ten trials raised concerns during credibility screening and were placed in a „pending” category until clarified by their authors. These trials were not included in the analysis because the concerns remained unresolved. The authors note that previous reviews often included a broader range of studies, including those based solely on radiographic diagnosis of osteoarthritis, non-oral turmeric preparations, or curcumin products combined with other active substances. Older reviews also did not apply the same trial credibility screening procedures.

Why trial credibility matters

Differences in study selection and methodology, including trial credibility assessment, may explain why the new Cochrane report reached more cautious conclusions than previous reviews. „This review highlights the importance of assessing clinical trial credibility,” adds Shirinsky. „These assessments help identify problematic studies that need further clarification before their results can be used to inform treatment effect conclusions.”

Clinical recommendations

When asked if he would recommend turmeric supplements to patients with knee osteoarthritis, Shirinsky responds: „I would not routinely recommend turmeric supplements to my patients with knee osteoarthritis. However, if a patient asks about them, I would explain what we know and what remains uncertain about the benefits and potential side effects, and help them make an informed decision.” The authors used the Trial Credibility Screening Tool developed by the Cochrane Pregnancy and Childbirth group. Similar tools have since been developed, including INSPECT-SR, designed to help researchers identify problematic studies that could distort evidence synthesis. Publication details: Curcuma longa (turmeric) or its active ingredients for osteoarthritis, Cochrane Database of Systematic Reviews (2026). DOI: 10.1002/14651858. CD014683.pub2 Journal information: Cochrane Library.

Leave a comment

Every comment is read before it goes live. You will see it published once approved. You can send at most 2 comments per hour.